AMS 700CX/CXM inflatable penile prosthesis has high mechanical reliability at long-term follow-up.
BACKGROUND
AMS 700CX/CXM inflatable penile prosthesis is increasingly applied for the treatment of erectile dysfunction (ED). However, there are a few long-term survival data of the inflatable penile prosthesis (IPP) over 10 years.


OBJECTIVE
To determine the long-term mechanical reliability of AMS 700CX/CXM inflatable penile prosthesis in patients with ED.


METHODS
A total of 438 consecutive patients with ED received implantation of an AMS 700CX/CXM penile prosthesis at our institution from January 1991 to April 2009. In 397 patients (90.7%), the medical records were available and current status of penile prosthesis could be obtained by a direct telephone interview. The overall and mechanical survival rates of penile prosthesis were evaluated using Kaplan-Meier method.


METHODS
Assessing the mechanical and overall survival rates of the AMS 700CX/CXM penile prosthesis using Kaplan-Meier analysis, and looking for clinical factors related to survival of the CX/CXM using log-rank test.


RESULTS
Mean age of 397 patients was 63.1 years (range, 24-93) and follow-up duration was 113 months (range 1-219). Eighty-two patients (20.6%) experienced mechanical failure at a median follow-up of 82 months. Mechanical survival rate of the penile prosthesis was 97.6%, 93.2% and 78.2% at 3, 5, and 10 years after implantation, respectively. 12 patients (3.0%) experienced nonmechanical failure including infections, tissue erosion resulting in cylinder protrusion at the meatus and chronic discomfort. Overall survival rate of the penile prosthesis was 95.0%, 91.0% and 75.5% at 3, 5, and 10 years after implantation, respectively. Patients with neurogenic cause for ED showed lower median overall survival of penile prosthesis compared with patients with non-neurogenic cause. Patient age, obesity, and diabetes mellitus had no association with overall survival of penile prosthesis after implantation.


CONCLUSIONS
The AMS 700CX/CXM could be accepted and applied in more patients as a reliable treatment alternative of ED.
Kim
Dong Suk
DS
Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Yang
Kwang Mo
KM
Chung
Hyun Jin
HJ
Choi
Hyun Min
HM
Choi
Young Deuk
YD
Choi
Hyung Ki
HK
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D018783:Impotence, Vasculogenic / Q000601:surgery / Q000628:therapy*; D053208:Kaplan-Meier Estimate; D007723:Korea; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D015917:Penile Prosthesis; D011183:Postoperative Complications; D011474:Prosthesis Design / Q000706:statistics & numerical data*; D011475:Prosthesis Failure; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D013997:Time Factors; D055815:Young Adult